Table 5 In vitro cumulative release % of curcumin and CCNF1-4 formulations.

From: Synthesis, characterization and evaluation of anti-arthritic and anti-inflammatory potential of curcumin loaded chitosan nanoparticles

Time (hour)

Drug

CCNF1

CCNF2

CCNF3

CCNF4

0

0

0

0

0

0

1

0

0.74

0.45

0.56

0.60

1.5

0.24

4.25

5.68

6.25

8.39

2

1.54

12.85

13.39

15.29

18.31

3

5.88

22.45

23.28

25.65

28.49

4

8.43

38.71

40.15

38.59

42.33

6

10.54

40.39

46.59

40.97

43.55

8

15.14

45.24

65.02

70.12

69.41

15

25.7

60.97

75.10

80.25

83.65

Back to article page